The rapidly accruing literature on Sandostatin indicates that it may be effective outside its current area of application, the treatment of symptomatic endocrine tumors of the GEP system. The following brief remarks and suggested future directions for Sandostatin represent ideas and comments from clinical research protocols and from reports on special applications presented in either abstract or publication form.


Growth Hormone Release Esophageal Variceal Biologic Response Modifier Secretory Diarrhea Esophageal Variceal Bleeding 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer Verlag, Berlin Heidelberg 1989

Authors and Affiliations

  • T. M. O’Dorisio
    • 1
  1. 1.College of MedicineThe Ohio State UniversityColumbusUSA

Personalised recommendations